More importantly, heparin-functionalized adsorbents could further exert beneficial effects by binding and depleting activated PF4 + platelets and PF4 + platelet extracellular vesicles, thereby contributing to the alleviation of immune thrombosis in sepsis and COVID-19 at multiple levels [35]. This evidence concerns the gene PF4 and COVID-19.